Anaphylaxis is defined by the World Allergy Association as “a serious, life-threatening generalized or systemic hypersensitivity reaction” and “a serious allergic reaction that is rapid in onset and might cause death”. There are not many clinical studies about the diagnosis and the management of anaphylaxis. This is a study made in the Emergency Department of Nuovo Ospedale Civile S. Agostino Estense of Modena lasted 1 year. Patients discharged or hospitalized with the diagnosis of allergic reaction, anaphylaxis, urticaria, and angioedema have been considered. 45 patients were included in the study. Cutaneous symptoms were the most frequent (93,3%), followed by respiratory symptoms (73,3%), cardiovascular symptoms (44,4%) and gastroenteric symptoms (13,3%). The management of anaphylaxis was not good because epinephrine was administred only in 24,4% of patients. At the discharge, counselling was made in 70,6% of patients. As the international medical literature underlines, it is necessary to improve the management of anaphylaxis above all the treatment (epinephrine must be the first drug to administer in the ED) and the counselling.

Diagnosi e gestione dell’ anafilassi nel dipartimento di emergenza urgenza: revisione della casistica clinica dell’ anno 2014 / Brugioni, L; Pigati, Stefano; Gozzi, C; Pinelli, G. - In: ITALIAN JOURNAL OF EMERGENCY MEDICINE. - ISSN 2532-1285. - (2015), pp. 45-52.

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2021